Reversibility of oncogene-induced cancer
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 14 (1) , 37-42
- https://doi.org/10.1016/j.gde.2003.12.008
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocationsBlood, 2003
- Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesisGenes & Development, 2003
- Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYCScience, 2002
- Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The Hallmarks of CancerCell, 2000
- Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic miceOncogene, 1999
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- Viral transformation of chick myogenic cellsExperimental Cell Research, 1979